Accuray's (ARAY) Radixact Treatment Delivery Platform Receives FDA 510(k) Clearance
- Wall Street jumps on upbeat retail guidance, easing Fed fears
- Broadcom (AVGO) to Acquire VMware (VMW) for Approximately $61 Billion in Cash and Stock
- NVIDIA (NVDA) Falls on Downbeat Guidance, Evercore ISI Remains a Buyer as Shares Trade Near an 'Estimated Floor of $150'
- Apple (AAPL) Stock Dips on Report It Expects Flat iPhone Production This Year
- Macy's (M) Stock Up 15% on Beat-and-raise, Goldman Sachs Says Results are a 'Bright Spot Among Retailers'
|Accuray Incorporated (NASDAQ: ARAY)||Delayed: 2.04 +0.02 (0.99%)|
|Previous Close||$2.02||52 Week High||$7.24|
|Open||$2.02||52 Week Low||$4.55|